Medical Information
 

In order to provide you with relevant and meaningful content we need to know more about you.

Please choose the category that best describes you.

This content is intended for U.S. Healthcare Professionals. Would you like to proceed?

If you provide additional keywords, you may be able to browse through our database of Scientific Response Documents.

Our scientific content is evidence-based, scientifically balanced and non-promotional. It undergoes rigorous internal medical review and is updated regularly to reflect new information.
Not a healthcare professional? Go to the patient or caregiver website.

VYNDAQEL® OR VYNDAMAX™ Principal Display Panel (tafamidis meglumine or tafamidis)

PRINCIPAL DISPLAY PANEL - 20 mg Capsule Blister Card

NDC 0069-1975-12

Vyndaqel®
(tafamidis meglumine) capsules

20 mg per capsule

Pfizer Labs.
LOT/EXP

PEEL & PUSH

PRINCIPAL DISPLAY PANEL - 20 mg Capsule Blister Card

PRINCIPAL DISPLAY PANEL - 20 mg Capsule Blister Card Carton

Vyndaqel® 20 mg per capsule*

(tafamidis meglumine) capsules

Attention Pharmacist: Vyndaqel is NOT substitutable on a per mg basis
with other tafamidis products.

NOT FOR INDIVIDUAL RESALE

Pfizer

Contains: A total of 30 capsules per carton.
Each carton contains 3 blister cards. Each
blister card contains 10 capsules.

Rx only

PRINCIPAL DISPLAY PANEL - 20 mg Capsule Blister Card Carton

PRINCIPAL DISPLAY PANEL - 20 mg Capsule Blister Card Carton Carton

NDC 0069-1975-40

Vyndaqel® 20 mg per capsule*

(tafamidis meglumine) capsules

Attention Pharmacist: Vyndaqel is NOT substitutable on a per mg basis with other
tafamidis products.

Pfizer

Contains: A total of 120 capsules per carton.
Each carton contains 4 intermediary cartons.
Each intermediary carton contains 3 blister
cards. Each blister card contains 10 capsules.

Rx only

PRINCIPAL DISPLAY PANEL - 20 mg Capsule Blister Card Carton Carton

PRINCIPAL DISPLAY PANEL - 61 mg Capsule Blister Card

NDC 0069-8730-01

Vyndamax™
(tafamidis) capsules

61 mg per capsule

Pfizer Labs.
LOT/EXP

PEEL & PUSH

PRINCIPAL DISPLAY PANEL - 61 mg Capsule Blister Card

PRINCIPAL DISPLAY PANEL - 61 mg Capsule Blister Card Carton

NDC 0069-8730-30

Vyndamax™
(tafamidis) capsules

61 mg per capsule

Attention Pharmacist: Vyndamax is NOT substitutable on a per mg basis with
tafamidis meglumine products.

Pfizer

Contains: A total of 30 capsules per carton.
Each carton contains 3 blister cards. Each
blister card contains 10 capsules.

Rx only

PRINCIPAL DISPLAY PANEL - 61 mg Capsule Blister Card Carton
Did you find an answer to your question? Yes No
Did you find an answer to your question? Yes No
Didn’t find what you were looking for? Contact us.

*Contact Medical Information. 9AM-5PM ET Monday to Friday; excluding holidays.

*9AM-5PM ET Monday to Friday; excluding holidays.

Submit a medical question for Pfizer prescription products.

Report Adverse Event

Contact Pfizer Safety to report an adverse event, side effect or concern about the quality of a Pfizer product: (800) 438-1985

You may also contact the U.S. Food and Drug Administration (FDA) directly to report adverse events or product quality concerns at 1-800-FDA-1088 or www.fda.gov/MedWatch